前收市價 | 173.83 |
開市 | 177.40 |
買盤 | 0.00 x 800 |
賣出價 | 0.00 x 1000 |
今日波幅 | 176.33 - 179.80 |
52 週波幅 | 132.24 - 243.52 |
成交量 | |
平均成交量 | 1,046,104 |
市值 | 26.124B |
Beta 值 (5 年,每月) | 0.67 |
市盈率 (最近 12 個月) | 29.41 |
每股盈利 (最近 12 個月) | 6.04 |
業績公佈日 | 2024年4月25日 |
遠期股息及收益率 | 1.92 (1.08%) |
除息日 | 2024年2月07日 |
1 年預測目標價 | 202.68 |
ResMed stock jumped Thursday after an analyst suggested the growing popularity of weight-loss drugs could drive use of its medical devices.
ResMed (RMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The company published some very good news from the lab, although it wasn't so encouraging for smaller rivals.